Published in Eur J Biochem on May 01, 1998
Production in Pichia pastoris of complementary protein-based polymers with heterodimer-forming WW and PPxY domains. Microb Cell Fact (2016) 0.75
Molecular composition of the adenovirus type 2 virion. J Virol (1985) 2.72
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. EMBO J (1989) 1.77
Amino acid analysis at the picomole level. Application to the C-terminal sequence analysis of polypeptides. Biochem J (1981) 1.76
The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J (1988) 1.61
Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53. J Med Chem (2000) 1.60
Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal Chem (1986) 1.52
[Tissue microarrays. Value of immunohistochemical proliferation markers for serial investigations of head and neck cancer]. HNO (2004) 1.41
PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas. Int J Cancer (2000) 1.37
Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature (1986) 1.37
Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis. Biochemistry (1992) 1.36
Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer (2002) 1.32
Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene (2006) 1.24
Amino acid analysis in the picomole range by precolumn derivatization and high-performance liquid chromatography. Methods Enzymol (1983) 1.24
L-DNAs as potential antimessenger oligonucleotides: a reassessment. Nucleic Acids Res (1993) 1.23
Op18/stathmin caps a kinked protofilament-like tubulin tetramer. EMBO J (2000) 1.16
Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J Biol Chem (1998) 1.09
Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol (2007) 1.07
Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J Antibiot (Tokyo) (1990) 1.05
Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. Biochem Pharmacol (1991) 1.04
Crystal structure of phosphoserine aminotransferase from Escherichia coli at 2.3 A resolution: comparison of the unligated enzyme and a complex with alpha-methyl-l-glutamate. J Mol Biol (1999) 1.04
The preparation and characterisation of native photoreceptor units from the thylakoids of Rhodopseudomonas viridis. EMBO J (1984) 1.02
Creating RNA bulges: cleavage of RNA in RNA/DNA duplexes by metal ion catalysis. Biochemistry (1996) 1.01
Optimized speech understanding with the continuous interleaved sampling speech coding strategy in patients with cochlear implants: effect of variations in stimulation rate and number of channels. Ann Otol Rhinol Laryngol (2000) 1.00
A new method for the selective isolation of cysteine-containing peptides. Specific labelling of the thiol group with a hydrophobic chromophore. Biochem J (1983) 0.99
Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation. Ann Oncol (2010) 0.98
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition. Biochemistry (1998) 0.96
Heteronuclear NMR assignments and secondary structure of the coiled coil trimerization domain from cartilage matrix protein in oxidized and reduced forms. Protein Sci (1997) 0.95
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol (2011) 0.95
Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid. FEBS Lett (1990) 0.95
Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. Anal Biochem (1983) 0.95
Results of cochlear implantation in patients with severe to profound hearing loss--implications for patient selection. Audiology (1999) 0.95
Dopamine and sensory tissue development in Drosophila melanogaster. J Neurobiol (2001) 0.94
Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol (1998) 0.94
The cross-reactive idiotype of anti-4-azobenzenearsonate hybridoma-derived antibodies in A/J mice constitutes multiple heavy chains. Hoppe Seylers Z Physiol Chem (1980) 0.93
Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis (2000) 0.93
[Infusion therapy in sudden deafness. Reducing the risk of pruritus after hydroxyethyl starch and maintaining therapeutic success--a prospective randomized study]. Laryngorhinootologie (1995) 0.92
Direct analysis of the disulfide content of proteins: methods for monitoring the stability and refolding process of cystine-containing proteins. Anal Biochem (1991) 0.91
Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature. Eur Arch Otorhinolaryngol (2012) 0.90
Location of disulphide bonds in human insulin-like growth factors (IGFs) synthesized by recombinant DNA technology. Biomed Environ Mass Spectrom (1988) 0.89
Accretion of structure in staphylococcal nuclease: an 15N NMR relaxation study. J Mol Biol (1996) 0.89
Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin. EMBO Rep (2001) 0.88
Membrane-mediated assembly of filamentous bacteriophage Pf1 coat protein. Science (1991) 0.88
Mechanism of action of glutaryl-CoA and butyryl-CoA dehydrogenases. Purification of glutaryl-CoA dehydrogenase. Biochemistry (1981) 0.88
Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology (2010) 0.87
Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis. Biochemistry (1992) 0.87
Polypurine/polypyrimidine hairpins form a triple helix structure at low pH. Nucleic Acids Res (1990) 0.87
Neutron diffraction studies of the structure of filamentous bacteriophage Pf1. Demonstration that the coat protein consists of a pair of alpha-helices with an intervening, non-helical surface loop. J Mol Biol (1991) 0.86
A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex. Structure (1997) 0.86
Recombinant human interleukin-12 is the second example of a C-mannosylated protein. Glycobiology (1999) 0.86
Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck. J Oral Pathol Med (2012) 0.86
A complete separation of dimethylaminoazobenzenesulphonyl-amino acids. Amino acid analysis with low nanogram amounts of polypeptide with dimethylaminoazobenzenesulphonyl chloride. Biochem J (1982) 0.84
Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol (2010) 0.84
[Counseling concepts and services of health-associated self-help initiatives]. Gesundheitswesen (1996) 0.84
Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes. Radiology (1989) 0.84
Mechanism of action of butyryl-CoA dehydrogenase: reactions with acetylenic, olefinic, and fluorinated substrate analogues. Biochemistry (1982) 0.84
Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans? Microbes Infect (2010) 0.84
[Quality assessment according to DIN EN ISO 9001:2000: certification in a university ENT department]. HNO (2006) 0.83
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. Cancer Chemother Pharmacol (2001) 0.83
10,20-Methanorhodopsins: (7E,9E,13E)-10,20-methanorhodopsin and (7E,9Z,13Z)-10,20-methanorhodopsin. 11-cis-locked rhodopsin analog pigments with unusual thermal and photo-stability. Eur J Biochem (1990) 0.83
Separation, purification, and sequence identification of TGF-beta 1 and TGF-beta 2 from bovine milk. J Protein Chem (1991) 0.82
Mass spectrometric characterization of stathmin isoforms separated by 2D PAGE. J Mass Spectrom (1999) 0.82
Biochemical interactions and metabolic fate of riot control agents. Fed Proc (1971) 0.82
Use of representational difference analysis and cDNA arrays for transcriptional profiling of tumor tissue. Ann N Y Acad Sci (2000) 0.82
Aspects of the molecular structure and dynamics of neuropeptide Y. Eur J Biochem (1999) 0.81
Elastase-cathepsin G inhibitors eglin b and eglin c differ by a single Tyr----His substitution. A micro-method for the identification of amino-acid substitution. Biol Chem Hoppe Seyler (1985) 0.81
[Humidifier-associated disease in the general population]. Dtsch Med Wochenschr (2006) 0.81
[Long-term outcome after corrective surgery of the neuro- and viscerocranium of patients with simple and syndrome-related premature craniosynostosis]. Mund Kiefer Gesichtschir (1998) 0.81
Prognostic relevance of volumetric analysis in tumour specimens of hypopharyngeal cancer. Clin Otolaryngol (2007) 0.80
[Quality management: reduced waiting time and enhanced efficiency in a university ear, nose, and throat outpatient department]. HNO (2007) 0.80
Amino acid sequences of antibody light chain variable regions of pedigreed rabbits: kappa light chain K49-501 (allotype b4 anti-streptococcal group A-variant polysaccharide antibody). Hoppe Seylers Z Physiol Chem (1979) 0.80
Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up. Eur Arch Otorhinolaryngol (2013) 0.80
Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Cancer Res (2001) 0.80
New treatment strategies for HPV-positive head and neck cancer. Eur Arch Otorhinolaryngol (2013) 0.80
Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids. J Immunol Methods (1994) 0.80
Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT (2006) 0.79
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol (2015) 0.79
Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae. Eur J Biochem (1996) 0.79
Adhesion of amorphous polymers as a function of temperature probed with AFM force-distance curves. J Colloid Interface Sci (2005) 0.79
Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells. Eur J Biochem (1993) 0.79
[New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting]. HNO (2012) 0.79
Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J Immunol (1998) 0.79
Radiographic examination of patients with dehiscence of semicircular canals with digital volume tomography. Eur Arch Otorhinolaryngol (2012) 0.78
Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants. J Biochem (1992) 0.78
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study. Eye (Lond) (2012) 0.78
A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors. Protein Eng (1994) 0.78
Determination of aliphatic side-chain conformation using cross-correlated relaxation: application to an extraordinarily stable 2'-aminoethoxy-modified oligonucleotide triplex. J Am Chem Soc (2001) 0.78
Sequence-specific 1H and 15N assignment and secondary structure of transforming growth factor beta3. J Biomol NMR (2000) 0.78
Changing indications for cataract surgery: 1974 to 1988. Ophthalmic Surg (1990) 0.77
Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clin Otolaryngol (2008) 0.77
Eye banking and screening for Creutzfeldt-Jakob disease. Arch Ophthalmol (2001) 0.77
A sensitive peptide mapping method. Identification of three amino acid substitutions within two anti-azobenzenearsonate monoclonal antibody light chains. Eur J Biochem (1982) 0.77
[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]. Pneumologie (2010) 0.77
Receptor binding and biological activity of IL-1 alpha, IL-1 beta, IL-1 beta analogues and an IL-1 antagonist in A375 human melanoma cells. J Recept Res (1993) 0.77
Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis? Am J Clin Oncol (1997) 0.77
Isolation and crystallization of lambda exonuclease. Arch Biochem Biophys (1985) 0.77
Current concepts of organ preservation in head and neck cancer. Eur Arch Otorhinolaryngol (2010) 0.77